1. Home
  2. MCBS vs SVRA Comparison

MCBS vs SVRA Comparison

Compare MCBS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

N/A

Current Price

$36.28

Market Cap

992.1M

Sector

Finance

ML Signal

N/A

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$4.89

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCBS
SVRA
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
992.1M
1.1B
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
MCBS
SVRA
Price
$36.28
$4.89
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $11.06
AVG Volume (30 Days)
99.1K
★ 2.7M
Earning Date
10-23-2026
11-24-2026
Dividend Yield
★ 3.42%
N/A
EPS Growth
★ 4.76
N/A
EPS
★ 2.37
N/A
Revenue
N/A
N/A
Revenue This Year
$30.11
N/A
Revenue Next Year
$2.12
$9,266.31
P/E Ratio
$15.30
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$24.53
$4.13
52 Week High
$37.46
$7.01

Technical Indicators

Market Signals
Indicator
MCBS
SVRA
Relative Strength Index (RSI) 56.41 48.34
Support Level $33.88 $4.73
Resistance Level $37.11 $5.47
Average True Range (ATR) 0.96 0.32
MACD 0.01 0.04
Stochastic Oscillator 73.16 54.50

Price Performance

Historical Comparison
MCBS
SVRA

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: